Highly active antiretroviral therapy with or without mycophenolate mofetil in treatment-naive HIV-1 patients

Sanjay U.C. Sankatsing, Suzanne Jurriaans, Peter van Swieten, Frank van Leth, Marion Cornelissen, Frank Miedema, Joep M. A. Lange, Hanneke Schuitemaker, Jan M. Prins

AIDS · 2004 · 37 citations · 25 references

Abstract

The addition of MMF to a triple class antiretroviral regimen in treatment-naive patients does not significantly increase the plasma HIV-1 RNA decay rate or the decay rate of the latently infected cellular reservoir.

References

25